There is no penalty for moving slowly
Thus, any comparison must be based on existing data from liraglutide's phase 3 trials and retatrutide's phase 2 trials: According to a 2016 systematic review of 43 randomized trials, liraglutide has shown significant benefits for T2D, with doses ranging from 1.2-1.8mg/daily leading to HbA1c decreases between -0.9% and -2.2% over six months
Both tirzepatide and semaglutide were associated with increased risk of gastrointestinal adverse events compared with placebo at all doses, tirzepatide 15mg was associated with the highest risk for nausea (3.6 times), vomiting (4.4 times) and diarrhoea (2.0 times)
Without knowing your individual bioavailability, you cannot know if you are getting a therapeutic dose
: "Cardiac energy dependence on glucose increases metabolites related to glutathione and activates metabolic genes controlled by mechanistic target of rapamycin." in: Journal of the American Heart Association , Vol
Additionally, maintaining a healthy diet and exercise regimen can help maximize the effects of the injections.